500,000 patients join massive gut disease study

NCT ID NCT05774080

Ongoing Knowledge-focused Sponsor: Target PharmaSolutions, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study is following up to 500,000 adults with chronic gastrointestinal diseases like Crohn's disease, ulcerative colitis, and eosinophilic GI disease. Researchers will collect data from electronic health records and patient reports to understand how these conditions progress over time and how well current treatments work. The goal is to improve care and outcomes for people living with these long-term gut disorders.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better understand how chronic GI diseases progress and which treatments work best for different patients.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may take years and might not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease digestive system disorder eosinophilic gastrointestinal disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROINTESTINAL DISEASES

Contacts and locations

Locations

Atrium Health/Wake Forest University School of Medicine

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.